CPF_0859 (C. perfringens ATCC 13124 )
In pDONR221 (Gateway donor/master vector)

Explanation of Terms

Gene:
Gene Symbol:  CPF_0859
Gene Name:  alpha-N-acetylglucosaminidase
Original Clone ID:
BGH89_B01c
Keyword:
partial CDS
Species:
Clostridium perfringens ATCC 13124
Type:
cDNA
Vector Name:
pDONR221
Format: 
CLOSED
Source:
Glyco-enzyme clone collection
Description:
All clones in the PSI Materials Repository related to human and bacterial glycosylation enzymes (Glyco-enzyme clone collection) were generated through the support of NIH grant RR005351. All users of these clones are requested to cite this grant source on all publications employing these resources
Comments:
for N-term fusion with a TEV cleavage site (no start codon)
Mutation / Discrepancy:
No / No
Publications:
None
Authors:
University of Georgia
Center for Personalized Diagnostics
Arizona State University
Kelley Moremen
CpCD00405632
Price: 
Login for Pricing
AVAILABLE
No restriction
Special MTA: SPTA
Insert sequence: 2061nts
Open reading frame: 1 to 2061

GAGGTTTCTGATTCAGGAGATGGAAAGGTTTTAATAAAGGGGAATAATGGTGTTTCCTTA
GCATCAGGATTTAACTATTATTTAAAAAATTATTGTAATGTAAGTTACAATCCAATAATG
GGGTCTAATTTAAAAATGCCTGAAACAATGCCTTCTGTTGGGGAGAGAGTAGTTATAGAT
ACTCCATATGAGCATAGATATGCATTAAACTTTTGTACCTATTCTTATACAATGTCTTTC
TGGGATTGGGATCAATATGAAGAATTCCTAGATTGGTGTGCTATGAATGGGGTTAACTTA
GTTTTAGATATAATTGGACAAGAAGAGGTTTTAAGAAGAACCTTAAATGAATTTGGATAT
AGCGATGAAGAGGTTAAAGAATTTATTTCAGGACCTGCATATTTTGCTTGGTTCTATATG
CAAAATATGACTGGATTTGGAGGTCCACTTCCTAACGATTGGTTTGAGCAAAGAGCAGAG
CTTGGAAGAAAAATGCATGATAGAATGCAAAGTTTTGGAATAAATCCTGTTCTTCAAGGA
TACTCAGGTATGGTTCCAAGAGACTTTAAGGAAAAAAATCAAGAAGCACAAACTATTTCT
CAAGGGGGATGGTGTGGCTTTGATAGACCAGATATGCTTAAAACATATGTAAATGAAGGG
GAGGCAGATTATTTCCAAAAGGTTGCAGATGTTTTCTATGAAAAGCAAAAAGAAGTGTTT
GGAGATGTAACTAACTTCTATGGAGTAGATCCATTCCATGAGGGAGGAAATACTGGTGAT
TTAGATAATGGAAAGATATATGAAATAATTCAAAATAAGATGATAGAGCATGATAATGAT
GCAGTTTGGGTTATACAAAACTGGCAAGGAAATCCTAGTAATAATAAGTTAGAAGGATTA
ACTAAAAAAGACCAAGCTATGGTATTAGATCTTTTCTCAGAGGTAAGTCCAGACTGGAAT
AGATTAGAGGAAAGAGATTTACCATGGATTTGGAATATGCTTCATAATTTTGGAGGAAGA
ATGGGAATGGATGCAGCACCAGAAAAACTTGCAACAGAAATTCCTAAAGCCTTAGCTAAT
TCAGAGCATATGGTTGGTATAGGTATTACACCAGAGGCTATAAATACAAATCCTTTAGCG
TATGAACTTTTATTTGACATGGCTTGGACTAGAGATCAAATAAACTTTAGAACATGGACT
GAAGATTATATTGAAAGAAGATATGGTAAGACTAATAAAGAGATTTTAGAGGCTTGGAAT
ATTATATTAGACACTGCTTACAAAAAGAGAAATGATTATTACCAAGGTGCTGCTGAGTCT
ATTATAAATGCAAGACCAGGCTTTGGAATAAAAAGTGCTTCAACTTGGGGACATTCAAAA
ATAGTTTATGATAAGAGTGAATTTGAAAAAGCTATTGAAATATTTGCAAAGAACTATGAT
GAATTCAAAGATAGTGATGCATTCCTTTATGACTTTGCTGATATATTAAAACAATTATTA
GCTAACTCAGCTCAAGAATATTATGAGGTTATGTGTAATGCTTATAATAATGGAAATGGA
GAGAAATTTAAATTTGTTTCAGGAAAGTTTTTAGAACTTATAAAGCTTCAAGAGAGAGTA
TTATCAACTAGACCTGAATTCTTAATAGGAAATTGGATTGAAGATGCTAGAACTATGCTT
AAGGACTCTGATGATTGGACTAAGGACTTATTTGAATTTAATGCTAGAGCTTTAGTAACA
ACTTGGGGTTCAAGAAATAATGCTGACGGTGGTGGGCTTAAAGATTATTCTAATAGACAA
TGGTCAGGATTAACTGAGGATTATTATTATGCTAGATGGGAAAAATGGATAAATGGATTA
CAAGCTGAATTAGATGGAGGAGCTAAAGCCCCTAATATAGATTGGTTTAAGATGGAGTAT
GACTGGGTAAACAAGAAGAGTGATACAGATAAGCTTTATCCTACAGAAGCTTCTAATGAA
AACTTAGGAGAACTTGCTAAGATAGCCATGGAAAGTTATTCAGTAACTAATATGGATAAA
ATATTAGGTGAAAATGAATAG

Protein sequence predicted based on nucleotide sequence

EVSDSGDGKVLIKGNNGVSLASGFNYYLKNYCNVSYNPIMGSNLKMPETMPSVGERVVID
TPYEHRYALNFCTYSYTMSFWDWDQYEEFLDWCAMNGVNLVLDIIGQEEVLRRTLNEFGY
SDEEVKEFISGPAYFAWFYMQNMTGFGGPLPNDWFEQRAELGRKMHDRMQSFGINPVLQG
YSGMVPRDFKEKNQEAQTISQGGWCGFDRPDMLKTYVNEGEADYFQKVADVFYEKQKEVF
GDVTNFYGVDPFHEGGNTGDLDNGKIYEIIQNKMIEHDNDAVWVIQNWQGNPSNNKLEGL
TKKDQAMVLDLFSEVSPDWNRLEERDLPWIWNMLHNFGGRMGMDAAPEKLATEIPKALAN
SEHMVGIGITPEAINTNPLAYELLFDMAWTRDQINFRTWTEDYIERRYGKTNKEILEAWN
IILDTAYKKRNDYYQGAAESIINARPGFGIKSASTWGHSKIVYDKSEFEKAIEIFAKNYD
EFKDSDAFLYDFADILKQLLANSAQEYYEVMCNAYNNGNGEKFKFVSGKFLELIKLQERV
LSTRPEFLIGNWIEDARTMLKDSDDWTKDLFEFNARALVTTWGSRNNADGGGLKDYSNRQ
WSGLTEDYYYARWEKWINGLQAELDGGAKAPNIDWFKMEYDWVNKKSDTDKLYPTEASNE
NLGELAKIAMESYSVTNMDKILGENE*

Coding Sequence Details

Insert Sequence Verified?:
Y
Verification Method:
Sequence Verification
Mutations:
None
Discrepancy:
None
5' Linker Sequence:
None
3' Linker Sequence:
None

Recommended Growth Condition:

Distributed in bacterial strain:
DH5-alpha T1 phage resistant
Antibiotic Selection:
Host Type:  bacterial    Marker:  kanamycin
Bacterial Selection Condition: 50ug/mL kanamycin
Growth Condition: Growth with the single antibiotic in LB at 37 degrees is recommended.
Comments: Conditions for Gateway-type vectors in recombined (with insert) form and other kanamycin resistant vectors.
Protein Expression Results:
None
Recommended expression in:
Not Applicable